Retinal Stem Cells for Transplant in a Glaucoma Model
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006032
Acknowledgement
Summary
In patients with glaucoma, vision is lost because of the death of nerve cells in the eye called retinal ganglion cells. Although treatments exist for glaucoma, many patients still lose vision because of the continued loss of retinal ganglion cells. It is well recognized that stem cells offer hope for the treatment of many diseases. Dr. van der Kooy’s laboratory was the first to describe the isolation of retinal stem cells from adult human and adult mouse eyes. When these stem cells are transplanted into mice, they have the remarkable capacity to integrate into the host retina. Furthermore, retinal stem cells can form all the major cell types that are found in the retina, including retinal ganglion cells. Dr. van der Kooy plans to transplant adult mouse retinal stem cells into the eyes of mice that have glaucoma and see whether these cells can replace lost retinal ganglion cells. This research will lead towards a day when it will be possible to take just a few retinal stem cells from a patient’s eye, expand their numbers in the lab, and then return them to that same patient in order to treat glaucoma.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute